Credit Suisse Ag Medicinova Inc Transaction History

Credit Suisse Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$2.1 - $2.6 $420 - $520	200 Added 20.0%	1,200 $3,000
Q2 2022 Aug 12, 2022	BUY	$2.31 - $3.14 $2,310 - $3,140	1,000 New	1,000 $3,000
Q1 2021 May 14, 2021	SELL	$4.81 - $8.74 $58,807 - $106,855	-12,226 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.03 - $6.31 $61,496 - $77,146	12,226 New	12,226 $65,000
Q4 2019 Feb 12, 2020	SELL	$6.48 - $8.76 $281,264 - $380,227	-43,405 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$7.7 - $10.42 $242,834 - $328,615	31,537 Added 265.73%	43,405 $346,000
Q2 2019 Aug 14, 2019	BUY	$8.29 - $13.22 $6,084 - $9,703	734 Added 6.59%	11,868 $114,000
Q1 2019 May 14, 2019	BUY	$6.82 - $10.27 $5,537 - $8,339	812 Added 7.87%	11,134 $92,000
Q4 2018 Feb 13, 2019	BUY	$7.65 - $12.83 $78,963 - $132,431	10,322 New	10,322 $85,000
Q3 2018 Nov 13, 2018	SELL	$7.06 - $12.49 $108,138 - $191,309	-15,317 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$7.96 - $13.23 $173,687 - $288,678	-21,820 Reduced 58.76%	15,317 $122,000
Q1 2018 May 15, 2018	BUY	$6.6 - $13.91 $176,840 - $372,704	26,794 Added 259.05%	37,137 $380,000
Q4 2017 Feb 14, 2018	SELL	$5.89 - $7.21 $91,919 - $112,519	-15,606 Reduced 60.14%	10,343 $67,000
Q3 2017 Nov 14, 2017	SELL	$4.43 - $6.58 $29,056 - $43,158	-6,559 Reduced 20.18%	25,949 $165,000
Q2 2017 Aug 14, 2017	BUY	N/A	32,508	32,508 $172,000

4.69M

7.2K

3.8K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $103M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.